# QCT in ALS Diagnosis, Mechanistic Understanding and Follow-up

> **NCT06284161** · NA · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 30 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DIAGNOSTIC_TEST:** Quadriceps Combined Test

## Key facts

- **NCT ID:** NCT06284161
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-28
- **Primary completion:** 2025-06-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06284161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06284161, "QCT in ALS Diagnosis, Mechanistic Understanding and Follow-up". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06284161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*